Evidence mapPaperPMID 41392113Full record

ArticleScientific reports2025

Triglyceride-glucose index for predicting the post-procedural wound healing of Rutherford grade 5 ischemia: a retrospective study.

Mohan Zhou, Jie Zhang, Tao Pan, Jianyu Hou, Qun Ma, Siyi Zhong, Longshuang Wang, Donghua Ji

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohan ZhouDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Jie ZhangDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Tao PanDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Jianyu HouDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Qun MaDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Siyi ZhongDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Longshuang WangDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China.
Donghua JiDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, People's Republic of China. nickji@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triglyceride-glucose (TyG) index has come to be a new insulin resistance (IR) marker and has also been independently linked with peripheral artery disease (PAD). Rutherford Grade 5 ischemia is characterized by localized tissue loss or active ulceration, with critically compromised perfusion, a high propensity for infection, and a narrow healing window-making it the most refractory and precarious tipping point in limb-salvage therapy, where progression to amputation is most likely. The present study attempted to evaluate the clinic utility of the TyG index in predicting the post-procedural wound healing of Rutherford grade 5 ischemia. This analysis incorporated 98 cases of chronic limb-threatening ischemia (CLTI) classified as Rutherford grade 5, treated via endovascular approaches from January 2016 to December 2022. This study applied univariate logistic regression to discern independent predictors, alongside computing receiver operating characteristic (ROC) curves to evaluate prognostic accuracy for wound recovery after interventions in these individuals. For deeper analysis of contributing elements, the cohort was split retrospectively and randomly into training (n = 68, 70%) and validation (n = 30, 30%) groups. Leveraging training set information, both univariate and multivariate logistic regressions enabled the formulation of a nomogram to forecast healing post-revascularization in Rutherford grade 5 ischemia. Assessment of the model's effectiveness involved ROC evaluations, calibration assessments, and decision curve analysis (DCA). The results showed that the TyG index was statistically significant in Rutherford grade 5 patients (p = 0.011). Univariate analysis indicated that the TyG index was an independent risk factor (OR: 3.96, 95% CI: 1.33-11.73, p = 0.013), and it's area under the ROC curve (AUC) for predicting delayed wound healing was 0.68, with a best cutoff value of 8.83, sensitivity of 67.1%, and specificity of 71.4%. In the training cohort, the TyG index, triglyceride (TG), and smoking status were identified as independent predictors of wound healing after endovascular treatment in Rutherford grade 5 patients (all p < 0.05). A nomogram was constructed using these three variables, demonstrating an AUC of 0.83 (95% CI: 0.71-0.95) in the training set and 0.68 (95% CI: 0.45-0.91) in the validation set, with good calibration observed in both cohorts. DCA indicated that this model could provide additional net clinical benefit in the low cost-effectiveness ratio threshold range. The TyG index may be an independent risk factor for delayed wound healing in Rutherford grade 5 patients following endovascular therapy. The nomogram model incorporating TyG index, TG levels, and smoking status demonstrates good predictive performance for wound healing after revascularization in these patients, and may positively impact early diagnosis/treatment, prevention of overtreatment, and precision medicine with optimized resource allocation.Trial registration the registration number PJKSKY2024423 the date of registration 15th July 2024.

Indexed as

Blood GlucoseIschemiaTriglyceridesWound HealingAgedAged, 80 and overBiomarkersFemaleHumansMaleMiddle AgedPeripheral Arterial DiseasePrognosisRetrospective StudiesROC CurveBiomarkersBlood GlucoseTriglyceridesChronic limb-threatening ischemiaNomogramPeripheral arterial diseaseTriglyceride-glucoseWound healing

Identifiers

PMID41392113
PMCPMC12804785

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.